ofatumumab + DHAP

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

Lymphoma, Large-Cell, Diffuse

Phase 2

Phase II Study of Ofatumumab Plus Ifosfamide, Carboplatin, Etoposide (ICE) or Dexamethasone, Cytarabine, Cisplatin (DHAP) Chemotherapy Regimen in Relapsed/ Refractory Diffuse Large B Cell Lymphoma (DLBCL)

CompletedNCT00823719

GlaxoSmithKlineLymphoma, Large-Cell, Diffuse

Start: 2009-05-31End: 2011-09-30Updated: 2013-03-12

Phase 3

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy Followed by Autologous Stem Cell Transplant in Relapsed or Refractory Diffuse Large B Cell Lymphoma

CompletedNCT01014208

GlaxoSmithKlineLymphoma, Large-Cell, Diffuse

Start: 2010-03-31End: 2014-11-30Updated: 2015-08-07

Related Papers

Ofatumumab Versus Rituximab Salvage Chemoimmunotherapy in Relapsed or Refractory Diffuse Large B-Cell Lymphoma: The Orcharrd Study (OMB110928)

Blood2014-12-0625 citations

Ofatumumab in combination with ICE or DHAP chemotherapy in relapsed or refractory intermediate grade B-cell lymphoma.

2013-05-2152 citations